Christine Falk
Christine Falk
Professor für Transplantationsimmunologie, IFB-Tx, Medizinische Hochschule Hannover, MHH
Bestätigte E-Mail-Adresse bei mh-hannover.de
Titel
Zitiert von
Zitiert von
Jahr
SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues
CGK Ziegler, SJ Allon, SK Nyquist, IM Mbano, VN Miao, CN Tzouanas, ...
Cell 181 (5), 1016-1035. e19, 2020
13342020
Human NK cell education by inhibitory receptors for MHC class I
N Anfossi, P André, S Guia, CS Falk, S Roetynck, CA Stewart, V Breso, ...
Immunity 25 (2), 331-342, 2006
12192006
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
8582019
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with …
J Haas, A Hug, A Viehöver, B Fritzsching, CS Falk, A Filser, T Vetter, ...
European journal of immunology 35 (11), 3343-3352, 2005
4952005
Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection
M Hösel, M Quasdorff, K Wiegmann, D Webb, U Zedler, M Broxtermann, ...
Hepatology 50 (6), 1773-1782, 2009
3442009
Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth
E Schlecker, A Stojanovic, C Eisen, C Quack, CS Falk, V Umansky, ...
The Journal of Immunology 189 (12), 5602-5611, 2012
3362012
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
C Meyer, A Sevko, M Ramacher, AV Bazhin, CS Falk, W Osen, I Borrello, ...
Proceedings of the National Academy of Sciences 108 (41), 17111-17116, 2011
3142011
Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients
N Halama, I Zoernig, A Berthel, C Kahlert, F Klupp, M Suarez-Carmona, ...
Cancer cell 29 (4), 587-601, 2016
2812016
Interferon-γ and tumor necrosis factor-α produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis
Y Xia, D Stadler, J Lucifora, F Reisinger, D Webb, M Hösel, T Michler, ...
Gastroenterology 150 (1), 194-205, 2016
2432016
Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines
N Halama, M Braun, C Kahlert, A Spille, C Quack, N Rahbari, M Koch, ...
Clinical Cancer Research 17 (4), 678-689, 2011
2252011
Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum
M Baratin, S Roetynck, C Lépolard, C Falk, S Sawadogo, S Uematsu, ...
Proceedings of the National Academy of Sciences 102 (41), 14747-14752, 2005
1932005
Rapid suppression of cytokine transcription in human CD4+ CD25− T cells by CD4+ Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-β, and various inhibitors of …
N Oberle, N Eberhardt, CS Falk, PH Krammer, E Suri-Payer
The Journal of Immunology 179 (6), 3578-3587, 2007
1712007
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system
T Luft, S Dietrich, C Falk, M Conzelmann, M Hess, A Benner, F Neumann, ...
Blood, The Journal of the American Society of Hematology 118 (6), 1685-1692, 2011
1682011
Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity
K Herzer, CS Falk, J Encke, ST Eichhorst, A Ulsenheimer, B Seliger, ...
Journal of virology 77 (15), 8299-8309, 2003
1662003
Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma
MGM Roemer, RA Redd, FZ Cader, CJ Pak, S Abdelrahman, J Ouyang, ...
Journal of Clinical Oncology 36 (10), 942, 2018
1642018
Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma
JS Schleypen, N Baur, R Kammerer, PJ Nelson, K Rohrmann, EF Gröne, ...
Clinical Cancer Research 12 (3), 718-725, 2006
1482006
Classical Hodgkin lymphoma with reduced β2M/MHC class I expression is associated with inferior outcome independent of 9p24. 1 status
MGM Roemer, RH Advani, RA Redd, GS Pinkus, Y Natkunam, AH Ligon, ...
Cancer immunology research 4 (11), 910-916, 2016
1202016
Impairment of wound healing in patients with type 2 diabetes mellitus influences circulating microRNA patterns via inflammatory cytokines
S Dangwal, B Stratmann, C Bang, JM Lorenzen, R Kumarswamy, ...
Arteriosclerosis, thrombosis, and vascular biology 35 (6), 1480-1488, 2015
1192015
Genetic evolution of T-cell resistance in the course of melanoma progression
A Sucker, F Zhao, B Real, C Heeke, N Bielefeld, S Maβen, S Horn, I Moll, ...
Clinical Cancer Research 20 (24), 6593-6604, 2014
1182014
Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes
JS Schleypen, M Von Geldern, EH Weiß, N Kotzias, K Rohrmann, ...
International journal of cancer 106 (6), 905-912, 2003
1172003
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20